<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been reported that <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in the <z:hpo ids='HP_0001417'>X-linked</z:hpo> GATA1 gene are present in hematological clonal disorders in children with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> (DS) </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed retrospective samples of DS children with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, transient <z:hpo ids='HP_0001909'>leukemia</z:hpo> (TL), and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) to test whether the specificity of GATA1 mutations can be helpful in distinguishing these hematopoietic disorders </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 49 samples were subjected to GATA1 mutation screening by direct sequencing and denaturing <z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gel electrophoresis (PAGE) </plain></SENT>
<SENT sid="3" pm="."><plain>Mutations in exon 2 of GATA1 were detected in six of eight DS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M7 samples and in four of six DS-TL; no mutation was detected in 13 children with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (DS-ALL), 6 with DS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (M0, M2, and M5), 6 with DS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and in 8 DS infants without <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> and 2 children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M7 without DS </plain></SENT>
<SENT sid="4" pm="."><plain>Blast cells proportion in the sample represented a critical aspect on the sensitivity of mutation detection in GATA1, and a combination of sequence analysis and PAGE is necessary to detect mutations when blast percentage is low </plain></SENT>
<SENT sid="5" pm="."><plain>The absence of detected mutations in any of the DS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases raises the question whether <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in DS children is an intermediate stage between TL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M7, as previously suggested </plain></SENT>
</text></document>